PNC Financial Services Group
VRDN icon

PNC Financial Services Group’s Viridian Therapeutics VRDN Stock Holding History

PNC Financial Services Group’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.05K Buy
207
+74
+56% +$2.2K ﹤0.01% 4357
2025
Q4 		$4.14K Sell
133
-64
-32% -$1.75K ﹤0.01% 4304
2025
Q3 		$4.25K Buy
197
+101
+105% +$1.82K ﹤0.01% 4272
2025
Q2 		$1.34K Sell
96
-766
-89% -$10.4K ﹤0.01% 4513
2025
Q1 		$11.6K Buy
862
+794
+1,168% +$13.5K ﹤0.01% 3771
2024
Q4 		$1.3K Sell
68
-7
-9% -$152 ﹤0.01% 4383
2024
Q3 		$1.71K Buy
75
+42
+127% +$687 ﹤0.01% 4322
2024
Q2 		$429 Buy
33
+13
+65% +$180 ﹤0.01% 4553
2024
Q1 		$350 Sell
20
-40
-67% -$775 ﹤0.01% 4535
2023
Q4 		$1.31K Buy
+60
New +$947 ﹤0.01% 4267

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return